2026-01-26 - Analysis Report
**Welltower (WELL) Financial Report**

---

### General Company Overview
Welltower is a healthcare real estate investment trust (REIT) company specializing in the ownership, management, and financing of high-quality properties connected to healthcare.

---

### Return Rate Comparison

| Ticker | Cumulative Return |
|--------|-------------------|
| WELL   | 183.52%           |
| VOO    | 126.41%           |

The cumulative return of Welltower (WELL) is 57.11% higher than the S&P 500 (VOO).

---

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 13.0% | 18.0% | 1.0%  | 0.5  | 47.6B  |
| 2017-2019  | 32.0% | 18.0% | 7.0%  | 0.3  | 56.1B  |
| 2018-2020  | 19.0% | 61.9% | -5.0% | 1.1  | 44.4B  |
| 2019-2021  | 17.0% | 61.9% | -48.0%| 1.3  | 58.9B  |
| 2020-2022  | -27.0% | 61.9% | -34.0%| 1.1  | 45.0B  |
| 2021-2023  | 46.0% | 36.6% | 26.0% | 0.7  | 61.9B  |
| 2022-2024  | 59.0% | 36.6% | 29.0% | 0.6  | 86.5B  |
| 2023-2025  | 163.0% | 14.1% | 87.0% | 0.5  | 127.4B |

---

### Recent Stock Price Fluctuations

- Close: $183.68
- Last-market: $183.68 (change: $0.95)
- 5-day SMA: $186.20
- 20-day SMA: $186.85
- 60-day SMA: $190.85

The current price is below the 20-day and 60-day SMA, indicating a potential downward trend.

---

### RSI, PPO Index Indicators

- RSI: 42.39
- PPO: -0.10
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)

The RSI is below 50, indicating that the stock may be undervalued. The PPO is slightly negative, indicating a potential downward trend.

---

### Recent News & Significant Events

- January 24, 2026: Assessing Welltower (WELL) Valuation As Shares Trade Near Recent Highs - Yahoo Finance
- January 25, 2026: Retirement Systems of Alabama Buys 9,365 Shares of Welltower Inc. $WELL - MarketBeat
- January 21, 2026: The Best-Performing Stocks in 2026 (By One-Year Returns) - NerdWallet
- January 25, 2026: (WELL.DB) Stock Market Analysis (WELL.DB:CA) - Stock Traders Daily
- January 21, 2026: Stock Market Today, Jan. 21: Vale Jumps After Trading Volume Surges Well Above Average - The Motley Fool
- January 22, 2026: Celestica Stock: Why Alphabet Looking Elsewhere Is Actually A Good Thing (NYSE:CLS) - Seeking Alpha

Recent news suggests that Welltower's stock price is performing well, with several institutional investors showing interest.

---

### Analyst Opinions

- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.65 (~Buy)
  - Opinions: 20
  - Target Price (avg/high/low): 209.70 / 260.00 / 162.00

Analysts have a neutral-to-bullish outlook on Welltower, with an average target price of $209.70.

---

### Recent Earnings Analysis

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-28 | 0.42 | 2.06 B$ |
| 2025-07-29 | 0.46 | 1.97 B$ |
| 2025-04-29 | 0.4 | 1.86 B$ |
| 2024-10-29 | 0.74 | 1.51 B$ |
| 2025-10-28 | 0.74 | 1.51 B$ |

The company has reported steady revenue growth, with earnings per share (EPS) fluctuating between $0.4 and $0.74.

---

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.63B | 39.99% |
| 2025-06-30 | $2.52B | 39.80% |
| 2025-03-31 | $2.39B | 38.78% |
| 2024-12-31 | $2.22B | 36.50% |
| 2024-09-30 | $2.01B | 39.70% |

Revenue has been steadily increasing over the past year, with a high profit margin of 39.99% in the latest quarter.

---

### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $38.76B | 0.72% |
| 2025-06-30 | $35.90B | 0.84% |
| 2025-03-31 | $33.96B | 0.76% |
| 2024-12-31 | $31.96B | 0.38% |
| 2024-09-30 | $30.33B | 1.48% |

Equity has been fluctuating over the past year, but ROE has shown a slight improvement.

---

### Comprehensive Analysis
Welltower's stock price has shown a high cumulative return, outperforming the S&P 500 in recent years. However, its earnings per share have fluctuated, and profit margins have varied over the past year. Analysts have a neutral-to-bullish outlook, while recent news suggests that institutional investors are showing interest in the company.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.